Novel Drug Delivery Systems (NDDS) Market
Novel Drug Delivery Systems (NDDS) Market Analysis By Route (Oral, Injectable, Pulmonary, Transdermal Drug Delivery Systems) By Mode (Targeted, Controlled & Modulated Drug Delivery Systems) and By Region – Global Market Insights 2022 to 2027
Analysis of Novel Drug Delivery Systems (NDDS) market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Novel Drug Delivery Systems (NDDS) Market Outlook
Worldwide demand for novel drug delivery systems (NDDS) is predicted to surge at a CAGR of 6.6% from 2022 to 2027. At present, the global novel drug delivery systems market enjoys a valuation of US$ 62.5 billion and is anticipated to climb to a market size of US$ 86 billion by the end of 2027.
Oral drug delivery systems are projected to be extremely popular over the coming years owing to their ease of administration and the increasing patient-centric approach of the healthcare sector.
Report Attributes |
Details |
|---|---|
|
Novel Drug Delivery Systems Market Size (2022) |
US$ 62.5 Billion |
|
Projected Year Value (2027F) |
US$ 86 Billion |
|
Global Market Growth Rate (2022-2027) |
6.6% CAGR |
|
Key Companies Profiled |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Demand Analysis of Novel Drug Delivery Systems (2017-2021) in Comparison to Market Growth Forecasts (2022-2027)
Drug delivery plays a crucial role in the treatment of any disease and hence has been a crucial aspect of the overall healthcare infrastructure. Conventional drug delivery systems are being replaced with advanced and modern drug delivery systems owing to their better efficacy and accuracy. This is expected to drive the novel drug delivery systems market at a CAGR of 6.6% over the next five years.
Increasing prevalence of chronic illnesses, rapid advancements in drug delivery technology, rising investments in the healthcare industry, favorable reimbursement policies, increasing R&D activities, the growing popularity of minimally invasive procedures, and advancements in drug formulation are expected to be prime factors that head the novel drug delivery systems market growth throughout the forecast period.
However, strict regulatory mandates are expected to have a constraining effect on the overall novel drug delivery systems market growth over the years to come. High costs of advanced healthcare procedures and lack of awareness of novel systems for drug delivery are other factors that could potentially restrain NDDS market growth to some extent over the next five years.
Which Prospects are Shaping NDDS Market Growth Path?
“Increasing Use of Drug Delivery Technology to Treat Chronic Diseases”
Drug delivery has been a crucial aspect of treatment for many diseases and with advancements in drug delivery, it has become more important in the treatment of most health conditions. The prevalence of chronic diseases such as cancer has increased exponentially over the past few years and this has led to high demand for novel systems for the delivery of drugs for the treatment procedures.
Drug delivery technology has offered some breakthrough treatment approaches for chronic diseases such as cancer and increasing research and development activities are expected to further advance the use of drug delivery in the treatment of other chronic illnesses.
“Stringent Regulatory Laws May Dwarf NDDS Market Potential”
Drug delivery systems need to undergo a crucial process of approval from regulatory bodies to be launched and used in the market. The presence of strict norms in the process of approval creates a challenge and hinders the overall novel drug delivery systems market potential. This factor is expected to maintain its restraining effect on the industry over the next five years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Regional Market Leads Novel Drug Delivery System Demand?
“North America to Majorly Drives Novel Drug Delivery System Sales”
North America novel drug delivery systems market currently accounts for a major market share and is anticipated to maintain a similar stance throughout the forecast period.
Rising healthcare expenditure, supportive government initiatives, and the presence of key drug delivery system providers are the prime factors that are expected to drive NDDS market growth in this region through 2027.
Increasing investments in the healthcare industry and the emergence of new molecular diagnostic companies in Europe are expected to be major factors that positively influence novel drug delivery system demand.
Rising incidence of chronic illnesses is also expected to favor NDDS market growth through 2027. Germany, Italy, Spain, France, and the United Kingdom are projected to be prime markets for novel drug delivery systems companies in this region.
The novel drug delivery systems market in the Asia Pacific region is expected to provide highly lucrative opportunities in the coming years. Increasing focus on healthcare, rising investments in R&D activities, growing demand for minimally invasive procedures, and increasing availability of modern drug delivery systems are anticipated to be key prospects that drive novel drug delivery systems market potential in this region.
China and India are anticipated to be the prime markets in this region owing to supportive government initiatives and rising investments in the healthcare research and development sector. Japan is also expected to be a noteworthy market in the APAC region over the next five years.
Analysts at Fact.MR, a market research and competitive intelligence provider, have created a comprehensive novel drug delivery systems market research report that lists all the crucial insights of the industry on a regional and segmental basis.
Country-wise Insights
How Can Manufacturers Earn Profits from the U.S. Market?
“Supportive Government Initiatives to Boost R&D Activities & High Healthcare Expenditure”
The market for novel drug delivery systems in the United States is expected to be primarily driven by increasing research and development activities in the country. Increasing investments in the R&D sector by the government and rising healthcare expenditure in the U.S. are also expected to favor novel drug delivery systems market potential through 2027.
Increasing availability of various drug delivery systems and the high prevalence of chronic diseases such as cancer are also anticipated to bolster novel drug delivery systems market growth in the country throughout the forecast period.
Category-wise Insights
Which Mode of Drug Delivery Will Be Popular Going Forward?
“Controlled Drug Delivery Systems to Maintain Dominant Market Stance”
The global novel drug delivery systems market based on mode is bifurcated into controlled drug delivery systems, targeted drug delivery systems, and modulated drug delivery systems.
Controlled drug delivery systems are anticipated to be widely preferred across the world over the coming years. The ability to offer controlled drug release from these delivery systems helps maximize the efficacy of the drug and is also pivotal in controlling drug toxicity. Improved patient outcomes are also expected to boost demand for controlled drug delivery systems across the forecast period.
Meanwhile, the demand for targeted drug delivery systems is projected to rise at the fastest CAGR through 2027. The increasing use of targeted drug delivery systems in cancer treatment is expected to drive their demand over the years to come.
Which Route of Administration is Popular in NDDS?
“Oral Drug Delivery Systems to Lead NDDS Market Potential”
The global novel drug delivery systems market, based on route, is segmented into oral drug delivery systems, injectable drug delivery systems, pulmonary drug delivery systems, transdermal drug delivery systems, and others.
High patient compliance is a major factor that drives the popularity of oral drug delivery systems across the world. Other factors that benefit the demand for oral drug delivery systems are ease of production and formulation, ease of administration, hassle-free storage, etc. This segment provides lucrative opportunities in the novel drug delivery systems marketplace over the coming years.
Novel ocular drug delivery systems and novel ophthalmic drug delivery systems are anticipated to witness a rise in popularity throughout the forecast period as advancements in the drug delivery industry pick up the pace.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Competitive Landscape
Key companies in the novel drug delivery systems market are expected to bolster their focus on the launch of new and modern drug delivery systems equipped with advanced technologies.
- In June 2022, Gulfic Biosciences Ltd., an innovative pharmaceutical company, announced the launch of a new drug delivery system. The new drug delivery system technology was developed by Gulfic and its French counterpart at an affordable price. The new system is called Dual Chamber Bags (DCB).
- In May 2022, Jabil Healthcare, a leading name in the healthcare industry, announced the launch of a reusable drug delivery device with a broader spectrum of applications. The Qfinity Autoinjector Platform will be available at lower costs than its market alternatives and is expected to further bolster the sustainability trend in the drug delivery industry owing to its reusable nature.
NDDS market players are also expected to eye acquisitions, partnerships, and mergers to enhance their business scope and expand their market presence across the world.
- Bayer, a German biotechnology and pharmaceutical organization, in August 2021, announced the acquisition of Vividion Therapeutics to strengthen its portfolio of novel drug discovery platforms. The acquisition was valued at US$ 1.5 billion.
- In June 2022, Accord Biopharma and EVERSANA partnered to launch the CAMCEVI (leuprolide) 42mg injection emulsion that is expected to be used for the treatment of prostate cancer in adults.
Key Segments of NDDS Industry Research
-
By Route :
- Oral Drug Delivery Systems
- Injectable Drug Delivery Systems
- Pulmonary Drug Delivery Systems
- Transdermal Drug Delivery Systems
- Others
-
By Mode :
- Targeted Drug Delivery Systems
- Controlled Drug Delivery Systems
- Modulated Drug Delivery Systems
-
By Region :
- North America
- Latin America
- Europe
- Asia Pacific
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Type modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. Product Type USPs /Technology 4.4. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New Product Type launches 5.2.2. Cost of Product Types 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Route 6.4.2. Revenue By Mode 6.4.3. Revenue By Country 6.5. 2021 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Novel Drug Delivery Systems (NDDS) Market Volume (Units) Analysis 2017-2021 and Forecast, 2022-2027 7.1. Historical Market Volume (Units) Analysis, 2017-2021 7.2. Current and Future Market Volume (Units) Projections, 2022-2027 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Novel Drug Delivery Systems (NDDS) Market - Pricing Analysis 8.1. Regional Pricing Analysis By Route 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Novel Drug Delivery Systems (NDDS) Market Value Analysis 2017–2021 and Forecast, 2022-2027 9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021 9.2. Current and Future Market Value (US$ Mn) Projections, 2022-2027 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027, by Route 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Routes & Services, 2017–2021 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route, 2022-2027 10.3.1. Oral Drug Delivery Systems 10.3.2. Injectable Drug Delivery Systems 10.3.3. Pulmonary Drug Delivery Systems 10.3.4. Transdermal Drug Delivery Systems 10.3.5. Others 10.4. Market Attractiveness Analysis By Route 11. Global Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027, by Mode 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Mode , 2017–2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mode , 2022-2027 11.3.1. Targeted Drug Delivery Systems 11.3.2. Controlled Drug Delivery Systems 11.3.3. Modulated Drug Delivery Systems 11.4. Market Attractiveness Analysis By Mode 12. Global Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2027 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Route 13.3.3. By Mode 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Route 14.3.3. By Mode 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Route 15.3.3. By Mode 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Route 16.3.3. By Mode 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Route 17.3.3. By Mode 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Route 18.3.3. By Mode 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2027 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Route 19.3.3. By Mode 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Novel Drug Delivery Systems (NDDS) Market Analysis 2017–2021 and Forecast 2022-2027 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Novel Drug Delivery Systems (NDDS) Market Analysis 20.2.1. By Route 20.2.2. By Mode 20.3. Canada Novel Drug Delivery Systems (NDDS) Market Analysis 20.3.1. By Route 20.3.2. By Mode 20.4. Mexico Novel Drug Delivery Systems (NDDS) Market Analysis 20.4.1. By Route 20.4.2. By Mode 20.5. Brazil Novel Drug Delivery Systems (NDDS) Market Analysis 20.5.1. By Route 20.5.2. By Mode 20.6. U.K. Novel Drug Delivery Systems (NDDS) Market Analysis 20.6.1. By Route 20.6.2. By Mode 20.7. Germany Novel Drug Delivery Systems (NDDS) Market Analysis 20.7.1. By Route 20.7.2. By Mode 20.8. France Novel Drug Delivery Systems (NDDS) Market Analysis 20.8.1. By Route 20.8.2. By Mode 20.9. Italy Novel Drug Delivery Systems (NDDS) Market Analysis 20.9.1. By Route 20.9.2. By Mode 20.10. Spain Novel Drug Delivery Systems (NDDS) Market Analysis 20.10.1. By Route 20.10.2. By Mode 20.11. BENELUX Novel Drug Delivery Systems (NDDS) Market Analysis 20.11.1. By Route 20.11.2. By Mode 20.12. Russia Novel Drug Delivery Systems (NDDS) Market Analysis 20.12.1. By Route 20.12.2. By Mode 20.13. China Novel Drug Delivery Systems (NDDS) Market Analysis 20.13.1. By Route 20.13.2. By Mode 20.14. Japan Novel Drug Delivery Systems (NDDS) Market Analysis 20.14.1. By Route 20.14.2. By Mode 20.15. South Korea Novel Drug Delivery Systems (NDDS) Market Analysis 20.15.1. By Route 20.15.2. By Mode 20.16. India Novel Drug Delivery Systems (NDDS) Market Analysis 20.16.1. By Route 20.16.2. By Mode 20.17. ASEAN Novel Drug Delivery Systems (NDDS) Market Analysis 20.17.1. By Route 20.17.2. By Mode 20.18. Australia Novel Drug Delivery Systems (NDDS) Market Analysis 20.18.1. By Route 20.18.2. By Mode 20.19. New Zealand Novel Drug Delivery Systems (NDDS) Market Analysis 20.19.1. By Route 20.19.2. By Mode 20.20. GCC Countries Novel Drug Delivery Systems (NDDS) Market Analysis 20.20.1. By Route 20.20.2. By Mode 20.21. Turkey Novel Drug Delivery Systems (NDDS) Market Analysis 20.21.1. By Route 20.21.2. By Mode 20.22. South Africa Novel Drug Delivery Systems (NDDS) Market Analysis 20.22.1. By Route 20.22.2. By Mode 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product Type foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. AstraZeneca PLC 22.3.1.1. Overview 22.3.1.2. Product Type Portfolio 22.3.1.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Boston Scientific 22.3.2.1. Overview 22.3.2.2. Product Type Portfolio 22.3.2.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.3. Genzyme Co. 22.3.3.1. Overview 22.3.3.2. Product Type Portfolio 22.3.3.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.4. Bayer AG 22.3.4.1. Overview 22.3.4.2. Product Type Portfolio 22.3.4.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.5. Novartis AG 22.3.5.1. Overview 22.3.5.2. Product Type Portfolio 22.3.5.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.6. Pfizer Inc. 22.3.6.1. Overview 22.3.6.2. Product Type Portfolio 22.3.6.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.7. Sanofi SA 22.3.7.1. Overview 22.3.7.2. Product Type Portfolio 22.3.7.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.8. Tolmar 22.3.8.1. Overview 22.3.8.2. Product Type Portfolio 22.3.8.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.9. GlaxoSmithKline PLC 22.3.9.1. Overview 22.3.9.2. Product Type Portfolio 22.3.9.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.10. Johnson & Johnson 22.3.10.1. Overview 22.3.10.2. Product Type Portfolio 22.3.10.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.11. Astellas 22.3.11.1. Overview 22.3.11.2. Product Type Portfolio 22.3.11.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.12. Aspen 22.3.12.1. Overview 22.3.12.2. Product Type Portfolio 22.3.12.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.13. Lupin 22.3.13.1. Overview 22.3.13.2. Product Type Portfolio 22.3.13.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.14. Breckenridge Pharmaceuticals 22.3.14.1. Overview 22.3.14.2. Product Type Portfolio 22.3.14.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.14.4. Sales Footprint 22.3.14.5. Strategy Overview 22.3.15. Shire 22.3.15.1. Overview 22.3.15.2. Product Type Portfolio 22.3.15.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.15.4. Sales Footprint 22.3.15.5. Strategy Overview 22.3.16. Galen 22.3.16.1. Overview 22.3.16.2. Product Type Portfolio 22.3.16.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.16.4. Sales Footprint 22.3.16.5. Strategy Overview 22.3.17. 3M Company 22.3.17.1. Overview 22.3.17.2. Product Type Portfolio 22.3.17.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.17.4. Sales Footprint 22.3.17.5. Strategy Overview 22.3.18. Merck & Co. Inc. 22.3.18.1. Overview 22.3.18.2. Product Type Portfolio 22.3.18.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.18.4. Sales Footprint 22.3.18.5. Strategy Overview 22.3.19. Teva Pharmaceuticals Industries Limited 22.3.19.1. Overview 22.3.19.2. Product Type Portfolio 22.3.19.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.19.4. Sales Footprint 22.3.19.5. Strategy Overview 22.3.20. Abbott Laboratories 22.3.20.1. Overview 22.3.20.2. Product Type Portfolio 22.3.20.3. Profitability by Market Segments (Product Type/Channel/Region) 22.3.20.4. Sales Footprint 22.3.20.5. Strategy Overview 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Novel Drug Delivery Systems (NDDS) Market Volume (‘000 Units) Analysis and Opportunity Assessment 2017–2027, By Route
Table 02: Global Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Route /p>
Table 03: Global Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Mode
Table 04: Global Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Region
Table 05: North America Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 06: North America Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Route
Table 07: North America Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Mode
Table 08: Latin America Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 09: Latin America Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Route
Table 10: Latin America Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Mode
Table 11: Europe Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 12: Europe Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Route
Table 13: Europe Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Mode
Table 14: South Asia Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 15: South Asia Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Route
Table 16: South Asia Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Mode
Table 17: East Asia Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 18: East Asia Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Route
Table 19: East Asia Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Mode
Table 20: Oceania Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 21: Oceania Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Route
Table 22: Oceania Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Mode
Table 23: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022–2027, By Country
Table 24: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Route
Table 25: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Value (US$ Mn) Analysis and Opportunity Assessment 2017–2027, By Mode
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Novel Drug Delivery Systems (NDDS) Market Volume (in 000' Units) Analysis, 2017-2021
Figure 02: Global Novel Drug Delivery Systems (NDDS) Market Volume Forecast (in 000' Units), 2022-2027
Figure 03: Novel Drug Delivery Systems (NDDS) Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 04: Novel Drug Delivery Systems (NDDS) Pricing Analysis (US$) Per Product Type, By Region, 2021
Figure 05: Global Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2017-2021
Figure 06: Global Novel Drug Delivery Systems (NDDS) Market Value Forecast (US$ Mn), 2022-2027
Figure 07: Global Novel Drug Delivery Systems (NDDS) Market Absolute $ Opportunity, 2022-2027
Figure 08: Global Novel Drug Delivery Systems (NDDS) Market Share Analysis (%), By Route, 2022-2027
Figure 09: Global Novel Drug Delivery Systems (NDDS) Market Y-o-Y Analysis (%), By Route, 2022-2027
Figure 10: Global Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Route, 2022-2027
Figure 11: Global Novel Drug Delivery Systems (NDDS) Market Share Analysis (%), By Mode, 2022-2027
Figure 12: Global Novel Drug Delivery Systems (NDDS) Market Y-o-Y Analysis (%), By Mode, 2022-2027
Figure 13: Global Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Mode, 2022-2027
Figure 14: Global Novel Drug Delivery Systems (NDDS) Market Share Analysis (%), By Region, 2022-2027
Figure 15: Global Novel Drug Delivery Systems (NDDS) Market Y-o-Y Analysis (%), By Region, 2022-2027
Figure 16: Global Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Region, 2022-2027
Figure 17: North America Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 18: North America Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 19: North America Novel Drug Delivery Systems (NDDS) Market Value Share, By Country, 2022 (E)
Figure 20: North America Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2017-2021
Figure 21: North America Novel Drug Delivery Systems (NDDS) Market Value Forecast (US$ Mn), 2022-2027
Figure 22: North America Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Route, 2022-2027
Figure 23: North America Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Mode, 2022-2027
Figure 24: North America Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Country, 2022-2027
Figure 25: Latin America Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 26: Latin America Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 27: Latin America Novel Drug Delivery Systems (NDDS) Market Value Share, By Country, 2022 (E)
Figure 28: Latin America Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2017-2021
Figure 29: Latin America Novel Drug Delivery Systems (NDDS) Market Value Forecast (US$ Mn), 2022-2027
Figure 30: Latin America Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Route, 2022-2027
Figure 31: Latin America Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Mode, 2022-2027
Figure 32: Latin America Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Country, 2022-2027
Figure 33: Europe Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 34: Europe Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 35: Europe Novel Drug Delivery Systems (NDDS) Market Value Share, By Country, 2022 (E)
Figure 36: Europe Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2017-2021
Figure 37: Europe Novel Drug Delivery Systems (NDDS) Market Value Forecast (US$ Mn), 2022-2027
Figure 38: Europe Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Route, 2022-2027
Figure 39: Europe Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Mode, 2022-2027
Figure 40: Europe Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Country, 2022-2027
Figure 41: South Asia Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 42: South Asia Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 43: South Asia Novel Drug Delivery Systems (NDDS) Market Value Share, By Country, 2022 (E)
Figure 44: South Asia Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2017-2021
Figure 45: South Asia Novel Drug Delivery Systems (NDDS) Market Value Forecast (US$ Mn), 2022-2027
Figure 46: South Asia Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Route, 2022-2027
Figure 47: South Asia Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Mode, 2022-2027
Figure 48: South Asia Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Country, 2022-2027
Figure 49: East Asia Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 50: East Asia Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 51: East Asia Novel Drug Delivery Systems (NDDS) Market Value Share, By Country, 2022 (E)
Figure 52: East Asia Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2017-2021
Figure 53: East Asia Novel Drug Delivery Systems (NDDS) Market Value Forecast (US$ Mn), 2022-2027
Figure 54: East Asia Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Route, 2022-2027
Figure 55: East Asia Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Mode, 2022-2027
Figure 56: East Asia Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Country, 2022-2027
Figure 57: Oceania Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 58: Oceania Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 59: Oceania Novel Drug Delivery Systems (NDDS) Market Value Share, By Country, 2022 (E)
Figure 60: Oceania Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2017-2021
Figure 61: Oceania Novel Drug Delivery Systems (NDDS) Market Value Forecast (US$ Mn), 2022-2027
Figure 62: Oceania Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Route, 2022-2027
Figure 63: Oceania Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Mode, 2022-2027
Figure 64: Oceania Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Country, 2022-2027
Figure 65: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 66: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 67: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Value Share, By Country, 2022 (E)
Figure 68: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2017-2021
Figure 69: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Value Forecast (US$ Mn), 2022-2027
Figure 70: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Route, 2022-2027
Figure 71: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Mode, 2022-2027
Figure 72: Middle East and Africa Novel Drug Delivery Systems (NDDS) Market Attractiveness Analysis by Country, 2022-2027
Figure 73: U. S. Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 74: U. S. Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 75: U. S. Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 76: Canada Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 77: Canada Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 78: Canada Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 79: Mexico Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 80: Mexico Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 81: Mexico Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 82: Brazil Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 83: Brazil Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 84: Brazil Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 85: U. K. Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 86: U. K. Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 87: U. K. Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 88: Germany Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 89: Germany Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 90: Germany Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 91: France Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 92: France Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 93: France Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 94: Italy Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 95: Italy Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 96: Italy Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 97: Spain Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 98: Spain Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 99: Spain Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 100: Russia Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 101: Russia Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 102: Russia Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 103: China Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 104: China Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 105: China Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 106: Japan Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 107: Japan Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 108: Japan Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 109: South Korea Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 110: South Korea Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 111: South Korea Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 112: India Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 113: India Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 114: India Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 115: ASEAN Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 116: ASEAN Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 117: ASEAN Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 118: Australia Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 119: Australia Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 120: Australia Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 121: New Zealand Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 122: New Zealand Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 123: New Zealand Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 124: GCC Countries Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 125: GCC Countries Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 126: GCC Countries Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 127: Turkey Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 128: Turkey Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 129: Turkey Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Figure 130: South Africa Novel Drug Delivery Systems (NDDS) Market Value Analysis (US$ Mn), 2022 & 2027
Figure 131: South Africa Novel Drug Delivery Systems (NDDS) Market Value Share, By Route, 2022 (E)
Figure 132: South Africa Novel Drug Delivery Systems (NDDS) Market Value Share, By Mode, 2022 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the novel drug delivery systems market?
The global novel drug delivery systems market stands at US$ 62.5 billion valuation.
What is the projected NDDS market value?
By 2027, the novel drug delivery systems market is expected to reach US$ 86 billion.
How will demand for novel drug delivery systems evolve?
Demand for novel drug delivery systems is slated to rise at 6.6% CAGR through 2027.
Which key market players are profiled in this Fact.MR analysis?
Astellas, Aspen, Lupin, Breckenridge Pharmaceuticals, Shire, Galen, 3M Company, Merck & Co. Inc., Teva Pharmaceuticals Industries Limited, and Abbott Laboratories are leading market players.
Which mode of administration will remain popular in NDDS?
In terms of mode, the novel drug delivery systems market will be dominated oral drug delivery systems.
Novel Drug Delivery Systems (NDDS) Market